Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lersivirine vs Etravirine in Experienced HIV-1 Patients
NCT00823979Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of lersivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Pfizer. Started Mar 2009; status: terminated.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00823979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823979.